consideration of dose escalation 6 months : Formal assessment of treatment efficacy according to appropriate criteria: For diabetes (NICE NG28): HbA1c reduction of at least 11 mmol/mol (1.0%) and weight loss of at least 3% For weight management: At least 5% weight loss from baseline on maintenance dose (per SmPC and NICE guidance) Annually thereafter : Ongoing monitoring of metabolic parameters, cardiovascular risk factors, and treatment appropriateness Treatment adjustments may be necessary if: Side effects remain intolerable despite supportive measures Weight loss plateaus before reaching target (may warrant dose increase if not at maximum) Inadequate glycaemic control persists (may require additional diabetes medications) Significant weight loss goals are achieved (maintenance strategies and potential dose reduction) Patients should maintain open communication with their healthcare team, reporting both positive developments and concerns

Stress-associated neurobiological activity is linked with acute plaque instability via enhanced macrophage activity: a prospective serial 18F-FDG-PET/CT imaging assessment
Contact us today to learn more about how Semaglutide can be a part of your weight loss journey
Antyoksydanty: Glutathione, Niacynamid, Epilobium Angustifolium Extract (wierzbwka), Panthenol, Adenosine, Copper Tripeptide-1, Vitamin C (Ascorbic Acid): Neutralizuj wolne rodniki, wspieraj ochron przed przedwczesnym starzeniem i rozjaniaj cer
This can be especially beneficial for those with a weight-related condition, such as high blood pressure or metabolic syndrome
Advanced LC-MS characterization of GLP-1 peptides enables accurate structural elucidation